Medtronic launched a surgical system in the U.S. designed to immobilize the thoracic and cervical spine during complex procedures and assist surgeons with navigation.
The Infinity Occipitocervical-Upper Thoracic System features a multi-axial screw that can move 60 degrees in any direction, as well as 3.0mm and 5.5mm diameter screws for a range of patient demographics and clinical applications.
The system also includes a spectrum of implant materials and sizes, and can be paired with the company’s O-arm imaging and StealthStation navigation systems.
Medtronic announced the launch during the annual meeting of the North American Spine Society in Los Angeles, and plans to make the system available globally over the next year. The Infinity OCT System is indicated for conditions including degenerative disc disease, instability or deformity, tumors, and traumatic spinal fractures or traumatic dislocations.
Last month, Medtronic announced it would acquire the remainder of Mazor Robotics, a developer of digitally-assisted spine surgery guidance systems, and plans to merge the company with its own implants, navigation and imaging products.
The $1.6 billion deal is the culmination of a phased investment agreement between the two companies that began in 2016, and Medtronic plans to maintain Mazor’s site and team in Caesarea, Israel.
“We believe robotic-assisted procedures are the future of spine surgery, enhancing surgeons’ abilities to perform complex procedures with greater precision, consistency and control,” Geoff Martha, president of Medtronic’s Restorative Therapies Group, said at the time.
By: Conor Hale
Source: Fierce Biotech
Five years ago, GSK made headlines when it hired Emma Walmsley to become the first woman to run a major pharmaceutical company. Now the Big Pharma has brought in another woman to control the company’s finances. Julie Brown will be GSK’s next chief financial officer. Brown, currently the chief operating and financial officer at fashion and beauty brand Burberry Group, is set to replace Iain Mackay.
Moderna created a new role responsible for “building out the company’s organization to support its growing pipeline.” Starting first thing 2023, Juan Andres, Moderna’s manufacturing head, will step into this new role under the title president of strategic partnerships and enterprise expansion, the company said Thursday.
The latest takeover is anticipated to boost the presence of Torrent in the dermatology segment. Indian company Torrent Pharmaceuticals has signed a definitive agreement for the complete acquisition of Curatio Healthcare for $245.16m (Rs20bn).